The main purpose of the Better Care for PFAS Patients Act of 2026 is to ensure that there is ongoing, updated clinical guidance regarding the health effects of per- and polyfluoroalkyl substances (PFAS). These substances are commonly found in various industrial and consumer products and have been linked to adverse health effects. The legislation aims to improve public health responses and clinical practices related to PFAS exposure.